Nearly one in 10 develop AF after aortic valve surgery

More research is needed to identify optimal management strategies, researchers say

Patients who develop atrial fibrillation after transcatheter aortic valve replacement (TAVR) are more likely to die within one year of surgery than those who don't develop AF, shows US research.